Inflammatory, Hematological, and Biochemical Biomarkers in COVID‐19 Patients
Rebeccah M Ayako, Kirtika Patel, Isaac Ndede, Johan Nordgren, Marie Larrson, Simeon K Mining · 2024
Read Inflammatory, Hematological, and Biochemical Biomarkers in COVID‐19 Patients by Rebeccah M Ayako, Kirtika Patel, Isaac Ndede, Johan Nordgren, Marie Larrson, Simeon K Mining (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11621974.txt.
Description
Rebeccah Ayako and five colleagues published a 2024 study on blood markers in COVID-19 patients. The illness can jump from mild to life-threatening with little warning. Few lab signs reliably tell at admission who will worsen.
The team tested three families of blood markers: inflammation, blood counts, and body chemistry. They checked how well each tracks the course and severity of disease. A good marker set could sort patients early and aim care where it is needed most. The study weighs which markers earn a place in that early sort. Such sorting matters most where hospital beds and staff are scarce.
Catalog record
| CREATOR | Rebeccah M Ayako, Kirtika Patel, Isaac Ndede, Johan Nordgren, Marie Larrson, Simeon K Mining |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |